Endocrine Drugs
154 FDA-approved drugs
TheraRadar tracks 154 FDA-approved endocrine drugs from 87 companies across 14 drug classes, led by AbbVie, with 45 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Endocrine.
Endocrine Approvals by Year
1
'15
'16
1
'17
2
'18
1
'19
5
'20
3
'21
3
'22
1
'23
3
'24
2
'25
'26
Recent Endocrine Drug Approvals
PALSONIFY
PALTUSOTINE HYDROCHLORIDE
adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an o...
2025-09-25
CRINETICS
KHINDIVI
HYDROCORTISONE
KHINDIVI is indicated as replacement therapy in pediatric patients 5 years of age and older with adr...
2025-05-28
ETON
CRENESSITY
CRINECERFONT
CRENESSITY is indicated as adjunctive treatment to glucocorticoid replacement to control androgens i...
2024-12-13
NEUROCRINE
BYNFEZIA PEN
OCTREOTIDE ACETATE
treat ment of severe diarrhea and flushing episodes associated with metastatic carcinoid tumors...
2024-09-27
Sun Pharma
YORVIPATH
PALOPEGTERIPARATIDE
hypoparathyroidism in adults...
2024-08-09
ASCENDIS PHARMA BONE
NGENLA
SOMATROGON-GHLA
pediatric patients aged 3 years and older who have growth failure due to an inadequate secretion of ...
2023-06-27
Pfizer
KYZATREX
TESTOSTERONE UNDECANOATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2022-07-27
MARIUS
AZMIRO
TESTOSTERONE CYPIONATE
testosterone replacement therapy in males in conditions associated with a deficiency or absence of e...
2022-06-02
AZURITY
TLANDO
TESTOSTERONE UNDECANOATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2022-03-28
VERITY
RECORLEV
LEVOKETOCONAZOLE
endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an op...
2021-12-30
STRONGBRIDGE
LANREOTIDE ACETATE
LANREOTIDE ACETATE
adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic ...
2021-12-17
INVAGEN PHARMS
SKYTROFA
LONAPEGSOMATROPIN-TCGD
the: Treatment of pediatric patients 1 year and older who weigh at least 11...
2021-08-25
ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S
ALKINDI SPRINKLE
HYDROCORTISONE
ALKINDI SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insuf...
2020-09-29
ETON
SOGROYA
SOMAPACITAN-BECO
the: • Treatment of pediatric patients aged 2...
2020-08-28
Novo Nordisk
METYROSINE
METYROSINE
INDICATIONS AND USAGE Metyrosine capsules are indicated in the treatment of patients with pheochromo...
2020-07-24
AMNEAL
MYCAPSSA
OCTREOTIDE ACETATE
long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment...
2020-06-26
CHIESI
ISTURISA
OSILODROSTAT PHOSPHATE
endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or ...
2020-03-06
RECORDATI RARE
JATENZO
TESTOSTERONE UNDECANOATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2019-03-27
TOLMAR
XYOSTED (AUTOINJECTOR)
TESTOSTERONE ENANTHATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2018-09-28
ANTARES PHARMA INC
CINACALCET HYDROCHLORIDE
CINACALCET HYDROCHLORIDE
secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis ...
2018-03-08
Aurobindo Pharma
Showing the 20 most recent of 154 endocrine drugs. View all 154 →
Top Endocrine Companies
Endocrine Active Trials by Indication
45 active trials — the forward pipeline, not just approvals.
Growth Hormone Deficiency 15 Hyperthyroidism 11 Acromegaly 9 Hypothyroidism 6 Adrenal Insufficiency 4
All competitive landscapes → Endocrine Drug Classes
Recombinant Human Growth Hormone 6
Androgen 6
Corticosteroid 2
Catecholamine Synthesis Inhibitor 2
Somatostatin Analog 2
Provitamin D2 Compound 2
Thyroid Hormone Synthesis Inhibitor 2
Adrenocorticotropic Hormone 2
Corticotropin-releasing Factor Type 1 Receptor Antagonist 1
Cortisol Synthesis Inhibitor 1
Endocrine at a Glance
- Total Drugs
- 154
- Companies
- 87
- Drug Classes
- 14
- Active Trials
- 45
- Latest Approval
- 2025-09-25